319 related articles for article (PubMed ID: 15881032)
1. Challenges presented by nerve damage in leprosy.
Harboe M; Aseffa A; Leekassa R
Lepr Rev; 2005 Mar; 76(1):5-13. PubMed ID: 15881032
[TBL] [Abstract][Full Text] [Related]
2. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
Spierings E; De Boer T; Zulianello L; Ottenhoff TH
Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
[TBL] [Abstract][Full Text] [Related]
3. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae.
Spierings E; De Boer T; Zulianello L; Ottenhoff TH
Immunol Cell Biol; 2000 Aug; 78(4):349-55. PubMed ID: 10947859
[TBL] [Abstract][Full Text] [Related]
4. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.
Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM
Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
Spierings E; de Boer T; Wieles B; Adams LB; Marani E; Ottenhoff TH
J Immunol; 2001 May; 166(10):5883-8. PubMed ID: 11342602
[TBL] [Abstract][Full Text] [Related]
7. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
8. TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence.
Mattos KA; Oliveira VG; D'Avila H; Rodrigues LS; Pinheiro RO; Sarno EN; Pessolani MC; Bozza PT
J Immunol; 2011 Sep; 187(5):2548-58. PubMed ID: 21813774
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in peripheral nerve damage in leprosy with special reference to insights obtained from in vitro studies and the experimental mouse model.
Birdi TJ; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):345-54. PubMed ID: 14763884
[TBL] [Abstract][Full Text] [Related]
10. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium leprae-induced demyelination: a model for early nerve degeneration.
Rambukkana A
Curr Opin Immunol; 2004 Aug; 16(4):511-8. PubMed ID: 15245748
[TBL] [Abstract][Full Text] [Related]
12. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
Janaszek W
Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
[TBL] [Abstract][Full Text] [Related]
13. Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria.
Mshana RN; Humber DP; Harboe M; Belehu A
Clin Exp Immunol; 1983 May; 52(2):441-8. PubMed ID: 6345041
[TBL] [Abstract][Full Text] [Related]
14. Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study.
Verhagen CE; Wierenga EA; Buffing AA; Chand MA; Faber WR; Das PK
J Immunol; 1997 Nov; 159(9):4474-83. PubMed ID: 9379047
[TBL] [Abstract][Full Text] [Related]
15. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions.
Hagge DA; Oby Robinson S; Scollard D; McCormick G; Williams DL
J Infect Dis; 2002 Nov; 186(9):1283-96. PubMed ID: 12402198
[TBL] [Abstract][Full Text] [Related]
16. Leprous neuropathy.
de Freitas MR; Said G
Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798
[TBL] [Abstract][Full Text] [Related]
17. Lack of Mycobacterium leprae-specific uptake in Schwann cells.
Band AH; Bhattacharya A; Talwar GP
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):71-8. PubMed ID: 3086468
[TBL] [Abstract][Full Text] [Related]
18. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion.
Shimoji Y; Ng V; Matsumura K; Fischetti VA; Rambukkana A
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9857-62. PubMed ID: 10449784
[TBL] [Abstract][Full Text] [Related]
19. Differential in vitro modulation of Schwann cell proliferation by Mycobacterium leprae and macrophages in the murine strains, Swiss white and C57Bl/6.
Singh N; Birdi TJ; Antia NH
J Peripher Nerv Syst; 1998; 3(3):207-16. PubMed ID: 10959251
[TBL] [Abstract][Full Text] [Related]
20. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes.
Ford AL; Britton WJ; Armati PJ
J Neuroimmunol; 1993 Mar; 43(1-2):151-9. PubMed ID: 7681446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
